Scienture Holdings, Inc. (SCNX)

Scienture Holdings, Inc. is a specialty pharmaceutical company headquartered in Hauppauge, New York. The company was formerly known as TRxADE Health and took its current name after combining with Scienture, a developer of specialty drug products.

It focuses on developing and commercializing branded and specialty products that improve on existing medicines through new formulations and delivery methods, such as ready-to-use liquid versions of drugs normally available only as tablets. Its lead commercial product is Arbli, an oral suspension of losartan for hypertension, and its pipeline includes additional reformulated therapies.